OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

HTML PDF

Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
DOI: 10.1016/s0140-6736(06)69571-8
Authors: André J Scheen, Nick Finer, Priscilla Hollander, Michael D Jensen, Luc F Van Gaal
Institutions: University of Liège, University of Cambridge, Baylor University Medical Center, Mayo Clinic, Antwerp University Hospital
Language: English

Topic: Pharmacology and Obesity Treatment
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: rimonabant, type 2 diabetes, obesity, overweight, weight loss, HbA1c, cardiovascular risk factors, metabolic risk factors, metformin, sulfonylureas, hypocaloric diet, physical activity, adverse events, tolerability, dose comparison, depression, nausea
SDG: Good health and well-being

Open Access status: green

Funders: Abbott Laboratories, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Sanofi, Shionogi, Vlaamse regering, National Institutes of Health
OpenAlex ID: W2165284792
FWCI: 81.61
Cites: 57
Cited by: 740
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms